NCT Number: NCT02850575
Bone Fixation of Mpact Double Mobility Cup
This study aims to evaluate long term fixation of the Mpact Double Mobility cup trough IMAGIKA technology.
This study is active but is not currently recruiting participants.
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Clinique Générale, Annecy, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- primary hip replacement
- patients 18 to 80 years old
- patients who accept the follow-up schedule
Exclusion criteria
- femoral neck fracture
- patients requiring grafts
- progressive local or systemic infections
- patients presenting muscular deficiency, neuromuscular disease or vascular insufficiency of the involved limb
- patients suffering from diseases that can compromize the recovery to independent mobility
- patients with BMI > 40
- patients with cognitive diseases that can compromize their participation in the study
- patients living in geographical area not allowing the clinical follow-up to be performed
- patients participating in other biomedical research
- patients <18 years old
- patients > 80 years old
- pregnant or breast feeding women
Treatment and study plan
Primary outcomes
-
implant fixation trough IMAGIKA
Time frame: 10 years
implant fixation trough IMAGIKA
Secondary outcomes
-
Harris Hip Score
Time frame: preop, 3 months, 1, 2, 5, 10 years
Harris Hip Score
-
complications
Time frame: intraop, immediate postop, 3 months, 1, 2, 5, 10 years
complications
-
penetration of femoral head in the polyethylene insert trough IMAGIKA
Time frame: 3 months, 5 and 10 years
penetration of femoral head in the polyethylene insert trough IMAGIKA
-
implant stability trough standard x-ray
Time frame: 3 months, 1, 2, 5, 10 years
implant stability trough standard x-ray
-
implant survival trough Kaplan-Meier curve
Time frame: 3 months, 1, 2, 5, 10 years
implant survival trough Kaplan-Meier curve
-
implant fixation trough IMAGIKA
Time frame: 3 months and 5 years
implant fixation trough IMAGIKA
Sponsors and collaborators
Lead sponsor
Medacta International SA
Industry
Registry information
Official study title
Etude Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte Pour l'évaluation de la Fixation Osseuse d'Une Cupule hémisphérique, le Mpact® Double Mobilité
Important dates
- Study start
- 2014
- Primary completion
- 2030
- Study completion
- 2030
- First posted
- Aug 1, 2016
- Registry last updated
- Sep 29, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Suzetrigine in Total Hip Arthroplasty
NCT07226700
Agnosia, JOURNAVX
New York, United States
View Trial DetailsMorphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study
NCT00889148
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial DetailsBinaural Beats for Postoperative Pain and Anxiety Reduction
NCT07437469
Anxiety, Anxiety Disorders
Miami, Florida, United States
View Trial DetailsDressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study
NCT07471243
Surgical Wound, Total Hip Replacement
Bournemouth, Dorset, United Kingdom
View Trial Details